BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28086887)

  • 1. Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.
    Mas Dalmau G; Sant Arderiu E; Enfedaque Montes MB; Solà I; Pequeño Saco S; Alonso Coello P
    BMC Fam Pract; 2017 Jan; 18(1):3. PubMed ID: 28086887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.
    Hsu JC; Freeman JV
    Clin Pharmacol Ther; 2018 Aug; 104(2):301-310. PubMed ID: 29328506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.
    Hua H; Sur N; Lee L; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).
    Pipilis A; Farmakis D; Kaliambakos S; Goudevenos J; Lekakis J;
    J Cardiovasc Med (Hagerstown); 2017 Jul; 18(7):545-549. PubMed ID: 26825445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.
    Wehbe RM; Yadlapati A
    Tex Heart Inst J; 2016 Aug; 43(4):287-90. PubMed ID: 27547134
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
    Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
    Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.
    Kea B; Alligood T; Robinson C; Livingston J; Sun BC
    Ann Emerg Med; 2019 Dec; 74(6):759-771. PubMed ID: 31080035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
    Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
    Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.
    Asinger RW; Shroff GR; Simegn MA; Herzog CA
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28893833
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Choice and Timing in Stroke Due to Atrial Fibrillation: A Survey of US Stroke Specialists (ACT-SAFe).
    Rybinnik I; Wong S; Mehta D; Leker RR; Mullen MT; Messé SR; Kasner SE; Cucchiara B
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105169. PubMed ID: 32912570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' and physicians' experiences of atrial fibrillation consultations and anticoagulation decision-making: A multi-perspective IPA design.
    Borg Xuereb C; Shaw RL; Lane DA
    Psychol Health; 2016; 31(4):436-55. PubMed ID: 26540308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.
    Giorgi-Pierfranceschi M; Artom N; Di Pasquale G; Squizzato A; Pellegrinet M; Romano G; Tana M; Mathieu G; Maggioni AP; Fontanella A; Campanini M; Mazzone A; Gussoni G; Dentali F
    Eur J Prev Cardiol; 2019 Apr; 26(6):660-663. PubMed ID: 30152250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.